| Real-world multicenter analysis of clinical outcomes and safety of meropenem-vaborbactam in patients treated for serious gram-negative bacterial infections S Alosaimy, SCJ Jorgensen, AM Lagnf, S Melvin, RP Mynatt, TJ Carlson, ... Open Forum Infectious Diseases 7 (3), ofaa051, 2020 | 42 | 2020 |
| Real-world, multicenter experience with meropenem-vaborbactam for gram-negative bacterial infections including carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa S Alosaimy, AM Lagnf, T Morrisette, MR Scipione, JJ Zhao, ... Open forum infectious diseases 8 (8), ofab371, 2021 | 38 | 2021 |
| Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection AJ Gonzales-Luna, AO Olaitan, WJ Shen, A Deshpande, TJ Carlson, ... Open forum infectious diseases 8 (8), ofab365, 2021 | 23 | 2021 |
| PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255 AJ Gonzales-Luna, TJ Carlson, KM Dotson, K Poblete, G Costa, ... Emerging Microbes & Infections 9 (1), 341-347, 2020 | 22 | 2020 |
| Early multicenter experience with imipenem-cilastatin-relebactam for multidrug-resistant gram-negative infections N Rebold, T Morrisette, AM Lagnf, S Alosaimy, D Holger, K Barber, ... Open Forum Infectious Diseases 8 (12), ofab554, 2021 | 21 | 2021 |
| Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain TJ Carlson, D Blasingame, AJ Gonzales-Luna, F Alnezary, KW Garey Anaerobe 62, 102142, 2020 | 21 | 2020 |
| Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection TJ Carlson, BT Endres, J Le Pham, AJ Gonzales-Luna, FS Alnezary, ... Open forum infectious diseases 7 (1), ofz552, 2020 | 16 | 2020 |
| Ridinilazole for the treatment of Clostridioides difficile infection TJ Carlson, BT Endres, E Bassères, AJ Gonzales-Luna, KW Garey Expert opinion on investigational drugs 28 (4), 303-310, 2019 | 16 | 2019 |
| Emerging Options for the Prevention and Management of Clostridioides difficile Infection AJ Gonzales-Luna, TJ Carlson, KW Garey Drugs 83 (2), 105-116, 2023 | 14 | 2023 |
| In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile K Begum, E Bassères, J Miranda, C Lancaster, AJ Gonzales-Luna, ... Antimicrobial Agents and Chemotherapy 64 (8), 10.1128/aac. 00522-20, 2020 | 13 | 2020 |
| Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies AJ Gonzales-Luna, TJ Carlson, KW Garey Gut Microbes 15 (1), 2223345, 2023 | 11 | 2023 |
| Antibiotic Treatment Pipeline for Clostridioides difficile Infection (CDI): A Wide Array of Narrow-Spectrum Agents TJ Carlson, AJ Gonzales-Luna Current Infectious Disease Reports 22, 1-11, 2020 | 11 | 2020 |
| National disparities in antibiotic prescribing by race, ethnicity, age group, and sex in United States ambulatory care visits, 2009 to 2016 EH Young, KA Strey, GC Lee, TJ Carlson, JM Koeller, VM Mendoza, ... Antibiotics 12 (1), 51, 2022 | 10 | 2022 |
| Fulminant Clostridioides difficile infection: a review of treatment options for a life-threatening infection TJ Carlson, AJ Gonzales-Luna, KW Garey Seminars in Respiratory and Critical Care Medicine 43 (01), 028-038, 2022 | 10 | 2022 |
| Challenges in drug discovery for intracellular bacteria AN Tucker, TJ Carlson, A Sarkar Pathogens 10 (9), 1172, 2021 | 9 | 2021 |
| Significant publications on infectious diseases pharmacotherapy in 2018 J Borjan, AJ Gonzales-Luna, TJ Carlson, NA Finch, AP Mitchell, ... Journal of Pharmacy Practice 32 (5), 546-557, 2019 | 9 | 2019 |
| Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use TJ Carlson, AJ Gonzales-Luna, MF Wilcox, SG Theriault, FS Alnezary, ... Open Forum Infectious Diseases 8 (10), ofab419, 2021 | 8 | 2021 |
| Assessment of Kidney Injury as a Severity Criteria for Clostridioides Difficile Infection TJ Carlson, AJ Gonzales-Luna, K Nebo, HY Chan, NLT Tran, S Antony, ... Open Forum Infectious Diseases 7 (11), ofaa476, 2020 | 8 | 2020 |
| In vitro activity of eravacycline against common ribotypes of Clostridioides difficile E Basseres, K Begum, C Lancaster, AJ Gonzales-Luna, TJ Carlson, ... Journal of Antimicrobial Chemotherapy 75 (10), 2879-2884, 2020 | 8 | 2020 |
| Clostridioides difficile Infection Treatment and Outcome Disparities in a National Sample of United States Hospitals EH Young, KA Strey, GC Lee, TJ Carlson, JM Koeller, KR Reveles Antibiotics 11 (9), 1203, 2022 | 7 | 2022 |
